The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Open accessAbstract
BACKGROUND: Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. METHODS: We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels. RESULTS: Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested. CONCLUSIONS: These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is likely that longer-term follow-up studies will reveal a further slowing of decay, with titres reaching a stable level analogous to humoral responses to other viral pathogens22,23.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [23]
In the citing paper
“Previous work has found that antibodies and memory B cells correlate for some vaccines or antigens, but do not correlate for many others (34).”
From Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination (2021) · cites this paper as [34]
In the citing paper
“We focused on the RBD since it is the target of the majority of the more potent SARS-CoV-2 neutralizing antibodies discovered to date21–26.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
In the citing paper
“Class 1 and 2 antibodies are among the most potent and also the most abundant antibodies7,8,21,22,25,39.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
In the citing paper
“The vaccines elicit antibody responses against the RBD, the major target of neutralizing antibodies21–26, in a manner that resembles natural infection.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
Citations
Cites
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,168
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Humoral Immunity Due to Long-Lived Plasma Cells
Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249
Self-citationCompetence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature reviews. Immunology · doi:10.1038/nri1886 · Cited by 1,033
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946
Self-citationLifetime of plasma cells in the bone marrow
Manz, R. A., Thiel, A., & Radbruch, A. (1997) · Nature · doi:10.1038/40540 · Cited by 866
Cutting edge: long-term B cell memory in humans after smallpox vaccination
Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P. G., Stewart, J. A., MOFENSON, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 606
Flagged first, then by citations
Research works printed but not linked: 3
- Bojlen K, 1955, Dan Med Bull, 2, 70
- Wolters KL, 1942, Zeitschrift fur Hyeitschrift, 124, 326
- Slifka MK. Mechanisms of antiviral immunity: studies on recombinant Listeria monocytogenes as a vaccine for inducing protective CTL memory and analysis of long-term antibody production after acute LCMV infection. Los Angeles: University of California, Los Angeles, 1996 (dissertation).
Cited by
Sorted by citations
Items 401–500 of 1,002
Vaccine approaches to malaria control and elimination: Insights from mathematical models
White, M. T., Verity, R., Churcher, T. S., & Ghani, A. C. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.099 · Cited by 40
Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
Karnasuta, C., Akapirat, S., Madnote, S., Savadsuk, H., Puangkaew, J., Rittiroongrad, S., Rerks‐Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., et al. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0204 · Cited by 39
Factors That Govern the Induction of Long-Lived Antibody Responses
Chackerian, B., & Peabody, D. S. (2020) · Viruses · doi:10.3390/v12010074 · Cited by 39
Animal Models of Varicella Zoster Virus Infection
Haberthur, K., & Messaoudi, I. (2013) · Pathogens · doi:10.3390/pathogens2020364 · Cited by 39
Calefi, A. S., de Siqueira, A., Namazu, L. B., Costola-de-Souza, C., Honda, B. T. B., Ferreira, A. J. P., Quinteiro-Filho, W. M., Fonseca, J. G. D. S., & Palermo‐Neto, J. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.02.004 · Cited by 39
What level of neutralising antibody protects from COVID-19?
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · doi:10.1101/2021.03.09.21252641 · Cited by 3,742
Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · doi:10.1101/2021.07.29.454333 · Cited by 275
Mohammadi, Y., Nezafat, N., Negahdaripour, M., Eskandari, S., & Zamani, M. (2022) · Immunologic Research · doi:10.1007/s12026-022-09351-3 · Cited by 38
Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage
Smits, G. P., Mollema, L., Hahné, S., de Melker, H. E., Tcherniaeva, I., van der Klis, F. R. M., & Berbers, G. A. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.066 · Cited by 38
Estimates of Mumps Seroprevalence May Be Influenced by Antibody Specificity and Serologic Method
Latner, D. R., McGrew, M., Williams, N. J., Sowers, S. B., Bellini, W. J., & Hickman, C. J. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00621-13 · Cited by 38
Immunological processes underlying the slow acquisition of humoral immunity to malaria
Ryg-Cornejo, V., Ly, A., & Hansen, D. S. (2016) · Parasitology · doi:10.1017/s0031182015001705 · Cited by 40
IgM memory B cells: specific effectors of innate-like and adaptive responses
Weill, J., & Reynaud, C. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.09.003 · Cited by 38
Lin, W.-H. W., Moran, E., Adams, R. J., Sievers, R. E., Hauer, D., Godin, S., & Griffin, D. E. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7799 · Cited by 38
Munitz, A., Edry‐Botzer, L., Itan, M., Tur‐Kaspa, R., Dicker, D., Marcoviciu, D., Goren, M. G., Mor, M., Lev, S., Gottesman, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83019-0 · Cited by 39
Effects of Aging on the Adaptive Immune Response to Respiratory Virus Infections
Fulton, R. B., & Varga, S. M. (2009) · Aging Health · doi:10.2217/ahe.09.69 · Cited by 39
Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition
Everly, M. J., Terasaki, P. I., Hopfield, J., Trivedi, H. L., & Kaneku, H. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ff87b1 · Cited by 37
Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
Lee, H.-J., & Choi, J. (2017) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2017.6.1.22 · Cited by 37
O’Connor, D., Png, E., Khor, C. C., Snape, M. D., Hill, A. V. S., van der Klis, F. R. M., Hoggart, C. J., Levin, M., Hibberd, M. L., & Pollard, A. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.053 · Cited by 37
Nicoli, F., Mantelli, B., Gallerani, E., Telatin, V., Bonazzi, I., Marconi, P., Gavioli, R., Gabrielli, L., Lazzarotto, T., Barzon, L., et al. (2020) · Vaccines · doi:10.3390/vaccines8010026 · Cited by 37
Kelly, D. F., Snape, M. D., Perrett, K. P., Clutterbuck, E., Lewis, S., Rohner, G. B., Jones, M., Yu, L., & Pollard, A. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02934.x · Cited by 37
Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease
Iversen, R., du Pré, M. F., Niro, R. D., & Sollid, L. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501363 · Cited by 37
Protective and pathogenic memory plasma cells
Hoyer, B. F., & Radbruch, A. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.04.014 · Cited by 36
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues
Davis‐Porada, J., George, A. B., Lam, N., Caron, D. P., Gray, J. I., Huang, J., Hwu, J., Wells, S. B., Matsumoto, R., Kubota, M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.003 · Cited by 41
HIV-associated memory B cell perturbations
Hu, Z., Luo, Z., Wan, Z., Wu, H., Li, W., Zhang, T., & Jiang, W. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.008 · Cited by 36
Mugyenyi, C. K., Elliott, S. R., Yap, X. Z., Feng, G., Boeuf, P., Fegan, G., Osier, F. H. A., Fowkes, F. J. I., Avril, M., Williams, T. N., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix370 · Cited by 36
Innate sensors that regulate vaccine responses
Georg, P., & Sander, L. E. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.006 · Cited by 36
Jeffery-Smith, A., Burton, A. R., Lens, S., Rees-Spear, C., Davies, J. E., Patel, M., Gopal, R., Muir, L., Aiano, F., Doores, K. J., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152042 · Cited by 37
Obesity accelerates age defects in B cells, and weight loss improves B cell function
Frasca, D., Romero, M., Diaz, A., & Blomberg, B. B. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00361-9 · Cited by 36
Byers, A. M., Tapia, T. M., Sassano, E. R., & Wittman, V. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.02.018 · Cited by 36
Selleng, K., Schütt, A., Selleng, S., Warkentin, T. E., & Greinacher, A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02360.x · Cited by 36
Garber, D. A., O’Mara, L. A., Gangadhara, S., McQuoid, M. J., Zhang, X., Zheng, R., Gill, K., Verma, M., Yu, T., Johnson, B. A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00246-12 · Cited by 36
Immune Response to SARS-CoV-2 Vaccines
Bellamkonda, N., Lambe, U. P., Sawant, S. A., Nandi, S. S., Chakraborty, C., & Shukla, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071464 · Cited by 37
Advocating Vaccination of Adults Aged 60 Years and Older in Western Europe:
Michel, J., Chidiac, C., Grubeck‐Loebenstein, B., Johnson, R. W., Lambert, P. H., Maggi, S., Moulias, R., Nicholson, K. G., & Werner, H. (2009) · Rejuvenation Research · doi:10.1089/rej.2008.0813 · Cited by 35
Basics of memory B‐cell responses: lessons from and for the real world
Wong, R., & Bhattacharya, D. (2018) · Immunology · doi:10.1111/imm.13019 · Cited by 36
Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting
Joyner, C. J., Ley, A. M., Nguyen, D. C., Ali, M., Corrado, A., Tipton, C. M., Scharer, C. D., Tian, M., Woodruff, M. C., Hom, J., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101285 · Cited by 35
B cells and antibodies in refractory immune thrombocytopenia
Roeser, A., Lazarus, A. H., & Mahévas, M. (2023) · British Journal of Haematology · doi:10.1111/bjh.18773 · Cited by 34
Morris, S. E., Pitzer, V. E., Viboud, C. G., Metcalf, C. J. E., Bjørnstad, O. N., & Grenfell, B. T. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1245 · Cited by 34
Long Antibody Persistence and Transgenerational Transfer of Immunity in a Long-Lived Vertebrate
Ramos, R., Garnier, R., González‐Solís, J., & Boulinier, T. (2014) · The American Naturalist · doi:10.1086/678400 · Cited by 34
Nelson, A. N., Lin, W.-H. W., Shivakoti, R., Putnam, N. E., Mangus, L. M., Adams, R. J., Hauer, D., Baxter, V. K., & Griffin, D. E. (2020) · JCI Insight · doi:10.1172/jci.insight.134992 · Cited by 34
Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects
Zhang, J., Xing, S., Liang, D., Hu, W. G., Ke, C., He, J., Yuan, R., Huang, Y., Li, Y., Liu, D., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.791660 · Cited by 34
Immune Markers Associated with Host Susceptibility to Infection with West Nile Virus
Qian, F., Thakar, J., Yuan, X., Nolan, M. S., Murray, K. O., Lee, W. T., Wong, S. J., Meng, H., Fikrig, E., Kleinstein, S. H., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0074 · Cited by 34
Antiviral protection following immunization correlates with humoral but not cell‐mediated immunity
Panchanathan, V., Chaudhri, G., & Karupiah, G. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2009.110 · Cited by 34
Cotugno, N., Douagi, I., Rossi, P., & Palma, P. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/805151 · Cited by 35
Unraveling the mysteries of plasma cells
Schuh, W., Mielenz, D., & Jäck, H. (2020) · Advances in immunology · doi:10.1016/bs.ai.2020.01.002 · Cited by 38
Ward, S. M., Phalora, P. K., Bradshaw, D., Leyendeckers, H., & Klenerman, P. (2008) · The Journal of Infectious Diseases · doi:10.1086/591094 · Cited by 34
Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life
Murungi, L., Sondén, K., Odera, D., Oduor, L. B., Guleid, F. H., Nkumama, I. N., Otiende, M., Kangoye, D. T., Fegan, G., Färnert, A., et al. (2016) · International Journal for Parasitology · doi:10.1016/j.ijpara.2016.09.005 · Cited by 33
B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination
Prabhu, P. R., Carter, J. J., & Galloway, D. A. (2022) · Vaccines · doi:10.3390/vaccines10060837 · Cited by 34
Taillardet, M., Haffar, G., Mondière, P., Asensio, M., Pléau-Pison, T., Burdin, N., Defrance, T., & Genestier, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/653739 · Cited by 33
Woods, C. W., Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D. H., Poore, E. A., Slifka, D. K., DeRaad, D. E. P., Amanna, I. J., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.026 · Cited by 33
Self-citationDesensitization in Crossmatch-positive Kidney Transplant Candidates
Noble, J., Jouvé, T., Malvezzi, P., & Rostaing, L. P. E. (2022) · Transplantation · doi:10.1097/tp.0000000000004279 · Cited by 32
Weiss, G. E., Ndungu, F. M., McKittrick, N. D., Li, S., Kimani, D., Crompton, P. D., Marsh, K., & Pierce, S. K. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.09.006 · Cited by 32
T cell vaccinology: Exploring the known unknowns
Burchill, M. A., Tamburini, B. A. J., Pennock, N. D., White, J. T., Kurche, J. S., & Kedl, R. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.096 · Cited by 33
How to cope with pathogenic long-lived plasma cells in autoimmune diseases
Hoyer, B. F., Mumtaz, I. M., Yoshida, T., Hiepe, F., & Radbruch, A. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098418 · Cited by 32
Tooze, R. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00460 · Cited by 33
Zaffina, S., Marcellini, V., Santoro, A. P., Scarsella, M., Camisa, V., Vinci, M. R., Musolino, A. M., Nicolosi, L., Rosado, M. M., & Carsetti, R. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.066 · Cited by 32
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity
Cagigi, A., Rinaldi, S., Cotugno, N., Manno, E. C., Santilli, V., Mora, N., Zangari, P., Aquilani, A., Tchidjou, H. K., Giaquinto, C., et al. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000144 · Cited by 31
Pasmans, H., Klooster, T. M. S.-V., Bogaard, M., van Rooijen, D. M., de Melker, H. E., Welters, M. J. P., van der Burg, S. H., van der Klis, F. R. M., & Buisman, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.066 · Cited by 31
Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences
Zaheer, T., Waseem, M., Waqar, W., Dar, H. A., Shehroz, M., Naz, K., Ishaq, Z., Ahmad, T., Ullah, N., Bakhtiar, S. M., et al. (2020) · PeerJ · doi:10.7717/peerj.9541 · Cited by 31
Blain, H., Tuaillon, É., Gamon, L., Pisoni, A., Miot, S., Rolland, Y., Picot, M., & Bousquet, J. J. (2021) · Allergy · doi:10.1111/all.15007 · Cited by 31
Takamatsu, Y., Omata, K., Shimizu, Y., Kinoshita, N., Terada, M., Suzuki, T., Morioka, S., Uemura, Y., Ohmagari, N., Maeda, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02716-22 · Cited by 35
MacNeil, A., Lee, C.-W., & DIETZ, V. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.005 · Cited by 31
Rizzi, M., Knoth, R., Hampe, C. S., Lorenz, P., Gougeon, M., Lemercier, B., Venhoff, N., Ferrera, F., Salzer, U., Thiesen, H.-J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010838 · Cited by 31
Moncunill, G., Mayor, A. G., Jiménez, A., Nhabomba, A. J., Casas-Vila, N., Puyol, L., Campo, J. J., Manaca, M. N., Aguilar, R., Pinazo, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073624 · Cited by 32
Do Long-Lived Plasma Cells Maintain a Healthy Microbiota in the Gut?
Jahnsen, F. L., Bækkevold, E. S., Hov, J. R., & Landsverk, O. J. B. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.10.006 · Cited by 32
Longevity of T-Cell Memory following Acute Viral Infection
Walker, J. M., & Slifka, M. K. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6451-9_8 · Cited by 30
Self-citationPuissant‐Lubrano, B., Bossi, P., Gay, F., Crance, J., Bonduelle, O., Garín, D., Bricaire, F., Autran, B., & Combadière, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38506 · Cited by 32
Hendrikx, L. H., de Rond, L., Öztürk, K., Veenhoven, R. H., Sanders, E. A. M., Berbers, G. A. M., & Buisman, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.094 · Cited by 30
McGuire, E., Fong, Y., Toote, C., Cunningham, C. K., McFarland, E. J., Borkowsky, W., Barnett, S. W., Itell, H. L., Kumar, A., Gray, G., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01070-17 · Cited by 31
Weinberger, B., Keller, M., Putzer, C., Breitenberger, D., Koller, B., Fiegl, S., Moreno‐Villanueva, M., Bernhardt, J. H., Franceschi, C., Voutetakis, K., et al. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.037 · Cited by 30
Immune surveillance for vaccine-preventable diseases
den Hartog, G., van Binnendijk, R. S., Buisman, A., Berbers, G. A. M., & van der Klis, F. R. M. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1745071 · Cited by 30
Samson, L. D., van den Berg, S. P. H., Engelfriet, P. M., Boots, A. M. H., Hendriks, M., de Rond, L., de Zeeuw‐Brouwer, M., Verschuren, W. M. M., Borghans, J. A. M., Buisman, A., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1193 · Cited by 30
The Wanderings of Gut-Derived IgA Plasma Cells: Impact on Systemic Immune Responses
Keppler, S. J., Goess, M. C., & Heinze, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670290 · Cited by 32
Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 31
Sundling, C., Martinez-Murillo, P., Soldemo, M., Spångberg, M., Bengtsson, K. L., Stertman, L., Forsell, M. N. E., & Hedestam, G. B. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis696 · Cited by 30
Mitchell, K. M., Mutapi, F., Savill, N. J., & Woolhouse, M. E. J. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002237 · Cited by 30
Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy
Lee, S. A., Bacchetti, P., Chomont, N., Fromentin, R., Lewin, S. R., O’Doherty, U., Palmer, S., Richman, D. D., Siliciano, J. D., Yukl, S. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160192 · Cited by 32
Haralambieva, I. H., Zimmermann, M. T., Ovsyannikova, I. G., Grill, D. E., Oberg, A. L., Kennedy, R. B., & Poland, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160970 · Cited by 30
Vertebrate Adaptive Immunity—Comparative Insights from a Teleost Model
Dickerson, H. W., & Findly, R. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01379 · Cited by 30
Klein, L. D., Huang, J., Quinn, E., Martin, M. A., Breakey, A. A., Gurven, M., Kaplan, H. S., Valeggia, C. R., Jasieńska, G., Scelza, B. A., et al. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy031 · Cited by 31
Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets
Hay, J. A., Laurie, K., White, M. T., & Riley, S. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007294 · Cited by 29
Targeting plasma cells in systemic autoimmune rheumatic diseases – Promises and pitfalls
Steinmetz, T. D., Verstappen, G. M. P. J., Suurmond, J., & Kroese, F. G. M. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.06.005 · Cited by 31
Ferreira‐Gomes, M., Chen, Y., Durek, P., Rincón-Arévalo, H., Heinrich, F., Bauer, L., Szelinski, F., Guerra, G. M., Stefanski, A., Niedobitek, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48570-0 · Cited by 29
Hay, J. A., Routledge, I., & Takahashi, S. (2024) · Epidemics · doi:10.1016/j.epidem.2024.100806 · Cited by 29
Spangler, A., Shimberg, G. D., Mantus, G. E., Malek, R., Cominsky, L. Y., Tsybovsky, Y., Li, N., Gillespie, R. A., Ravichandran, M., Creanga, A., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.004 · Cited by 29
Prelog, M., Almanzar, G., Rieber, N. P., Ottensmeier, B., Zlamy, M., & Liese, J. G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.105 · Cited by 29
Serology indicates cytomegalovirus infection is associated with varicella‐zoster virus reactivation
Ogunjimi, B., Theeten, H., Hens, N., & Beutels, P. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23749 · Cited by 29
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Upreti, S., & Samant, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03323-w · Cited by 29
Viral Vaccines and CTL Response
Woolard, S., & Kumaraguru, U. (2010) · BioMed Research International · doi:10.1155/2010/141657 · Cited by 29
van Twillert, I., den Brink, J. A. M. V. G.-V., Poelen, M. C. M., Helm, K., Kuipers, B., Schipper, M., Boog, C. J. P., Verheij, T. J., Versteegh, F. G. A., & van Els, C. A. C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085227 · Cited by 29
Aves, K.-L., Goksøyr, L., & Sander, A. F. (2020) · Viruses · doi:10.3390/v12020185 · Cited by 29
Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph node
Melo‐Silva, C. R., & Sigal, L. J. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01188-0 · Cited by 28
Oom, A. L., Wilson, K. K., Yonatan, M., Rettig, S., Youn, H. A., Tuen, M., Shah, Y., Dumont, A., Belli, H. M., Zucker, J. R., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00253-25 · Cited by 28
Mathematical modeling of diphtheria transmission in Thailand
Sornbundit, K., Triampo, W., & Modchang, C. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.05.031 · Cited by 28
B cells defined by immunoglobulin isotypes
James, L. K. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac091 · Cited by 28
Hendel, H., de Herve, M.-G. D. G., Giannesini, C., Mazet, A.-A., Papeix, C., Louapre, C., Chardain, A., Boutarfa, N., Théaudin, M., Adams, D., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00131-13 · Cited by 28
Gershon, A. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00162-4 · Cited by 28
Harris, K. E., Aldred, S. F., Davison, L. M., Ogana, H. A. N., Boudreau, A. A., Brüggemann, M., Osborn, M. J., Ma, B., Buelow, B., Clarke, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00889 · Cited by 28
Luque, S., Lúcia, M., Crespo, E., Jarque, M., Grinyo, J. M., & Bestard, O. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.07.011 · Cited by 28
Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4+ T Cells
Huang, Q., Hu, J., Tang, J., Xu, L., & Ye, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00249 · Cited by 28
Antibody Determinants of Influenza Immunity
Crowe, J. E. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz010 · Cited by 28
Metadata
- Authors
- Amanna, I. J., Carlson, N. E., & Slifka, M. K.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-11-08
- Volume
- 357
- Issue
- 19
- Pages
- 1903-1915
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2128666074
- Cited by
- 1,286
- References
- 38
- Citations by year
- 2026: 60 · 2025: 81 · 2024: 82 · 2023: 72 · 2022: 103 · 2021: 127 · 2020: 73 · 2019: 60 · 2018: 64 · 2017: 64 · 2016: 52 · 2015: 47 · 2014: 68 · 2013: 67 · 2012: 66
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG023664)
- National Center for Research Resources (RR000163, P51RR000163, M01RR000334, UL1RR024140, RR024140, RR 000334)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- humoral immunity, antibody half-life, memory B cells, long-term antibody persistence, vaccine antigens, measles, mumps, rubella, varicella-zoster virus, Epstein-Barr virus, tetanus toxoid, diphtheria toxoid, protective immunity
- MeSH terms
- Adult, Aging, Antibodies, Bacterial, Antibodies, Viral, Antibody Formation, Antigens, Bacterial, Antigens, Viral, B-Lymphocytes, Diphtheria, Female, Half-Life, Humans, Longitudinal Studies, Male, Middle Aged, Plasma Cells, Tetanus, Time Factors, Vaccines, Virus Diseases, Seroepidemiologic Studies, Lymphocyte Count
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review